Association of periodontitis with cognitive decline and its progression: Contribution of blood-based biomarkers of Alzheimer's disease to this relationship.

AIM To assess whether periodontitis is associated with cognitive decline and its progression as well as with certain blood-based markers of Alzheimer's disease. MATERIALS AND METHODS Data from a 2-year follow-up prospective cohort study (n = 101) was analysed. Participants with a previous history of hypertension and aged ≥60 years were included in the analysis. All of them received a full-mouth periodontal examination and cognitive function assessments (Addenbrooke's Cognitive Examination (ACE) and Mini-Mental State Examination [MMSE]). Plasma levels of amyloid beta (Aβ)1-40 , Aβ1-42 , phosphorylated and total Tau (p-Tau and t-Tau) were determined at baseline, 12 and 24 months. RESULTS Periodontitis was associated with poor cognitive performance (MMSE: β = -1.5 [0.6]) and progression of cognitive impairment (hazard ratio [HR] = 1.8; 95% confidence interval: 1.0-3.1). Subjects with periodontitis showed greater baseline levels of p-Tau (1.6 [0.7] vs. 1.2 [0.2] pg/mL, p < .001) and Aβ1-40 (242.1 [77.3] vs. 208.2 [73.8] pg/mL, p = .036) compared with those without periodontitis. Concentrations of the latter protein also increased over time only in the periodontitis group (p = .005). CONCLUSIONS Periodontitis is associated with cognitive decline and its progression in elderly patients with a previous history of hypertension. Overexpression of p-Tau and Aβ1-40 may play a role in this association.

[1]  T. Sobrino,et al.  Periodontitis is associated with subclinical cerebral and carotid atherosclerosis in hypertensive patients: A cross-sectional study , 2023, Clinical Oral Investigations.

[2]  R. Kelley,et al.  Emerging Concepts in Vascular Dementia: A Review. , 2021, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[3]  J. Valdés,et al.  Alzheimer’s Disease-Like Pathology Triggered by Porphyromonas gingivalis in Wild Type Rats Is Serotype Dependent , 2020, Frontiers in Immunology.

[4]  Queralt Miró Catalina,et al.  Is systemic inflammation a missing link between periodontitis and hypertension? Results from two large population‐based surveys , 2020, Journal of internal medicine.

[5]  D. Liang,et al.  Effects of Porphyromonas gingivalis and Its Underlying Mechanisms on Alzheimer-Like Tau Hyperphosphorylation in Sprague-Dawley Rats , 2020, Journal of Molecular Neuroscience.

[6]  T. Hortobágyi,et al.  An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders , 2020, Nature Reviews Neurology.

[7]  K. Blennow,et al.  Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia , 2020, Nature Medicine.

[8]  T. Sobrino,et al.  Periodontitis and Systemic Markers of Neurodegeneration. A case-control study. , 2020, Journal of clinical periodontology.

[9]  K. Blennow,et al.  Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration , 2020, Nature Medicine.

[10]  David A Bennett,et al.  Diagnosis and Management of Dementia: Review. , 2019, JAMA.

[11]  Cheng-En Sung,et al.  Association between periodontitis and cognitive impairment: Analysis of national health and nutrition examination survey (NHANES) III. , 2019, Journal of clinical periodontology.

[12]  T. Sobrino,et al.  Porphyromonas gingivalis lipopolysaccharide-induced periodontitis and serum amyloid-beta peptides. , 2019, Archives of oral biology.

[13]  D. Raha,et al.  Porphyromonas gingivalis in Alzheimer’s disease brains: Evidence for disease causation and treatment with small-molecule inhibitors , 2019, Science Advances.

[14]  T. Sobrino,et al.  Periodontitis as a risk indicator and predictor of poor outcome for lacunar infarct , 2018, Journal of clinical periodontology.

[15]  M. Ragozzino,et al.  Chronic oral application of a periodontal pathogen results in brain inflammation, neurodegeneration and amyloid beta production in wild type mice , 2018, PloS one.

[16]  J. Sanmartin Berglund,et al.  Longitudinal evaluation of periodontitis and development of cognitive decline among older adults , 2018, Journal of clinical periodontology.

[17]  C. Jack,et al.  Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau- and amyloid-positron emission tomography , 2018, Alzheimer's & Dementia.

[18]  Takashi Kasai,et al.  Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer’s disease and down syndrome , 2017, Molecular Neurodegeneration.

[19]  H. Zetterberg,et al.  Review: Tau in biofluids – relation to pathology, imaging and clinical features , 2017, Neuropathology and applied neurobiology.

[20]  A. Yoshihara,et al.  Longitudinal relationship of severe periodontitis with cognitive decline in older Japanese. , 2016, Journal of periodontal research.

[21]  B. Choi,et al.  Periodontitis Is Associated with Cognitive Impairment in Elderly Koreans: Results from the Yangpyeong Cohort Study , 2016, Journal of the American Geriatrics Society.

[22]  P. Eke,et al.  Update of the case definitions for population-based surveillance of periodontitis. , 2012, Journal of periodontology.

[23]  L. Mucke,et al.  Alzheimer Mechanisms and Therapeutic Strategies , 2012, Cell.

[24]  A. Spiro,et al.  Tooth Loss and Periodontal Disease Predict Poor Cognitive Function in Older Men , 2010, Journal of the American Geriatrics Society.

[25]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2007, Epidemiology.

[26]  F. Manes,et al.  Validation of the Spanish version of the Addenbrooke's Cognitive Examination in a rural community in Spain , 2006, International journal of geriatric psychiatry.

[27]  J. C. de la Torre,et al.  Alzheimer's disease is a vasocognopathy: a new term to describe its nature , 2004, Neurological research.

[28]  George A. Carlson,et al.  Exogenous Aβ1–40 Reproduces Cerebrovascular Alterations Resulting from Amyloid Precursor Protein Overexpression in Mice , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[29]  C. Iadecola,et al.  Abeta 1-40-related reduction in functional hyperemia in mouse neocortex during somatosensory activation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[30]  S. Younkin.  Evidence that Aβ42 is the real culprit in alzheimer's disease , 1995 .

[31]  D. Mann,et al.  Amyloid β protein (Aβ) deposition: Aβ42(43) precedes Aβ40 in down Syndrome , 1995, Annals of neurology.

[32]  S. Folstein,et al.  “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician , 1975 .